Neoadjuvant therapy using PD-1 inhibitor plus chemotherapy with different intervals between chemotherapy cycles for locally advanced gastric or gastroesophageal junction cancer: A randomized phase 2 study

被引：0
|
作者：
Gao, Quanli
Zhao, Lingdi
Zhao, Weijie
Wang, Zibing
Qin, Peng
Jiang, Zhiqiang
Huang, Jinxi
Zhang, Bin
Li, Zhimeng
Fu, Qiang
Zhao, Yuzhou
Ren, Yingkun
Shang, Chuang
Wan, Xiangbin
Gao, Yang
Xu, Yongchao
Yuan, Long
Lu, Chaomin
Li, Zhi
机构：
[1] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Immunol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[3] Henan Canc Hosp, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Surg Oncol, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[6] Zhengzhou Univ, Dept Surg Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4064
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A randomized phase II trial of neoadjuvant chemotherapy compared with chemoradiotherapy in locally advanced gastroesophageal and gastric adenocarcinoma
    Jin, J.
    Wang, X.
    Zhao, D. B.
    Chi, Y.
    Zhao, H.
    Yang, L.
    Zhou, A. P.
    Jiang, L. M.
    Tang, Y.
    Ren, H.
    Li, N.
    Liu, W. Y.
    Li, Y. X.
    ANNALS OF ONCOLOGY, 2015, 26 : 69 - 69
  • [22] First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
    Chen, Xiaofeng
    Xu, Hao
    Chen, Xiaobing
    Xu, Tongpeng
    Tian, Yitong
    Wang, Deqiang
    Guo, Fen
    Wang, Kangxin
    Jin, Guangfu
    Li, Xiao
    Wang, Rong
    Li, Fengyuan
    Ding, Yongbin
    Tang, Jie
    Fang, Yueyu
    Zhao, Jing
    Liu, Liang
    Ma, Ling
    Meng, Lijuan
    Hou, Zhiguo
    Zheng, Rongrong
    Liu, Yang
    Guan, Ni
    Zhang, Bei
    Tong, Shuang
    Chen, Shiqing
    Li, Xing
    Shu, Yongqian
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [23] First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
    Xiaofeng Chen
    Hao Xu
    Xiaobing Chen
    Tongpeng Xu
    Yitong Tian
    Deqiang Wang
    Fen Guo
    Kangxin Wang
    Guangfu Jin
    Xiao Li
    Rong Wang
    Fengyuan Li
    Yongbin Ding
    Jie Tang
    Yueyu Fang
    Jing Zhao
    Liang Liu
    Ling Ma
    Lijuan Meng
    Zhiguo Hou
    Rongrong Zheng
    Yang Liu
    Ni Guan
    Bei Zhang
    Shuang Tong
    Shiqing Chen
    Xing Li
    Yongqian Shu
    Signal Transduction and Targeted Therapy, 9
  • [24] Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma
    Gao, Wen
    Feng, Lifei
    Zhao, Xinming
    Huang, Zishi
    Chen, Duoxuan
    Yin, Gaofei
    Guo, Wei
    Zhong, Qi
    Chen, Xiaohong
    Fang, Jugao
    Zhang, Yang
    Huang, Zhigang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiation Therapy in Locally Advanced Gastroesophageal and Gastric Adenocarcinoma: Preliminary Results
    Wang, X.
    Zhao, D. B.
    Jin, J.
    Chi, Y.
    Yang, L.
    Tang, Y.
    Che, X.
    Zhao, H.
    Jiang, L. M.
    Ren, H.
    Liu, W., Jr.
    Li, N.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S32 - S32
  • [26] Pathological complete response following neoadjuvant chemotherapy with PD-1 inhibitor for locally advanced pancreatic cancer: case report
    Chen, Junsheng
    Wang, Da
    Xiong, Fei
    Wu, Guanhua
    Liu, Wenzheng
    Wang, Qi
    Kuai, Yiyang
    Peng, Feng
    Chen, Yongjun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06) : 2692 - 2705
  • [27] Apatinib plus SOX regimen as neoadjuvant chemotherapy for locally advanced gastric cancer: A phase II study.
    Zheng, Ya'nan
    Yang, Xiao
    Shi, Hongpeng
    Yang, Zhongyin
    Yan, Chao
    Ni, Zhentian
    Li, Mengjiao
    Sah, Birendra Kumar
    Liu, Wentao
    Xu, Wei
    Yao, Xuexin
    Zhu, Zhenglun
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
    Shen, Dijian
    Chen, Qixun
    Wu, Jie
    Li, Jianqiang
    Tao, Kaiyi
    Jiang, Youhua
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (01) : 1 - 10
  • [29] Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer
    Satake, Hironaga
    Kondo, Masato
    Mizumoto, Motoko
    Kotake, Takeshi
    Okita, Yoshihiro
    Ogata, Takatsugu
    Hatachi, Yukimasa
    Yasui, Hisateru
    Miki, Akira
    Imai, Yukihiro
    Ichikawa, Chihiro
    Murotani, Kenta
    Kotaka, Masahito
    Kato, Takeshi
    Kaihara, Satoshi
    Tsuji, Akihito
    ANTICANCER RESEARCH, 2017, 37 (07) : 3703 - 3710
  • [30] Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer
    Yoshikawa, T.
    Sasako, M.
    Yamamoto, S.
    Sano, T.
    Imamura, H.
    Fujitani, K.
    Oshita, H.
    Ito, S.
    Kawashima, Y.
    Fukushima, N.
    BRITISH JOURNAL OF SURGERY, 2009, 96 (09) : 1015 - 1022
12345